← Open Payments lookup

ANTHONY RAMICONE: Open Payments

NPI 1730690488 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$282 in 14 payments from 9 companies in 2025. Trend: 2023 $452 · 2024 $374 · 2025 $282

Food & beverage: $282
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$53
Amgen Inc.2$43
PFIZER INC.2$38
GlaxoSmithKline, LLC.2$36
Novo Nordisk Inc1$27
Antares Pharma, Inc.1$25
ABBVIE INC.1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$20
Aimmune Therapeutics, Inc.1$17

Products named: Wegovy, OTEZLA, XYOSTED, FARXIGA, QULIPTA, ELIQUIS, XIFAXAN, TRELEGY ELLIPTA.

Industry payments across RI — which companies pay providers there.